脑淀粉样血管病、痴呆与阿尔茨海默神经病理改变:ACT尸检队列研究结果
该研究基于ACT尸检队列848例,回顾性横断面分析显示脑淀粉样血管病(CAA)与痴呆相关(年龄性别校正OR 1.57,95%CI 1.18-2.10),但分别校正CERAD评分或Braak分期后关联不再显著;中介分析提示该关联可能由阿尔茨海默病神经病理改变中介。
要点
- CAA与痴呆的年龄性别校正OR为1.57(95%CI 1.18-2.10)。
- 校正CERAD评分后OR为1.27(95%CI 0.93-1.71),关联不显著。
- 校正Braak分期后OR为0.96(95%CI 0.69-1.33),关联不显著。
核心结论
- CAA与痴呆存在显著关联,但校正CERAD评分或Braak分期后关联消失;中介分析提示该关联可能由阿尔茨海默病神经病理改变中介,此假说需在未来机制研究中检验并考虑未测量混杂因素。
研究设计与样本
- 本研究为Kaiser Permanente Washington数据库成人思想变化(ACT)尸检队列的回顾性横断面分析。
- 共纳入848例参与者,死亡时平均年龄86.7±4.6岁,女性占57.6%。
- CAA通过免疫组化诊断,痴呆通过ACT共识诊断会议判定,AD神经病理按CERAD评分和Braak分期分类。
- 采用多变量 logistic 回归估计OR和95%CI,并校正死亡年龄和性别,另分别校正CERAD评分、Braak分期、APOE ε4和卒中。
- 进行正式中介分析估计CERAD评分和Braak分期的自然间接效应(NIE)的年龄性别校正OR(95%CI)。
主要发现
- CAA存在于322例参与者(38.0%),其中轻度152例、中度145例、重度25例。
- 痴呆存在于384例参与者(45.3%),其中317例有AD。
- CAA组痴呆比例高于无CAA组(53.7% vs 40.1%),年龄性别校正OR 1.57(95%CI 1.18-2.10)。
- 分别校正其他协变量后关联仍显著,但校正CERAD评分后OR 1.27(95%CI 0.93-1.71)、校正Braak分期后OR 0.96(95%CI 0.69-1.33),关联均不显著。
- 中介分析显示CERAD评分和Braak分期的NIE OR分别为1.25(95%CI 1.13-1.37)和1.63(95%CI 1.38-1.88),分别中介总关联的53%和111%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出该假说需在未来机制研究中检验,并需考虑未测量混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Cerebral amyloid angiopathy (CAA) is common in older adults and is associated with dementia. Less is known whether this association is mediated by Alzheimer disease (AD) neuropathologic changes, the examination of which was the objective of this study. METHODS: This was a retrospective cross-sectional examination of the Kaiser Permanente Washington database of the Adult Changes in Thought (ACT) autopsy cohort with information on CAA, dementia, the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) (amyloid neuritic plaques), and Braak (tau neurofibrillary tangles). CAA was diagnosed by immunohistochemistry and dementia by ACT Consensus Diagnostic Conference. AD neuropathology was categorized by CERAD scores and Braak stages. Multivariable logistic regression models were used to estimate odds ratios (ORs) and 95% CIs of the associations of CAA with dementia, adjusting for age at death and sex, and with additional adjustments separately for CERAD scores (moderate-severe vs mild-absent), Braak stages (V-VI vs 0-IV), APOE ε4, and stroke. Formal mediation analyses were conducted to estimate age-sex-adjusted OR (95% CI) for natural indirect effects (NIEs) of CERAD scores and Braak stages. RESULTS: The 848 participants had a mean age of 86.7 ± 4.6 years at death, and 57.6% were female. CAA was present in 322 participants (38.0%), of whom 152, 145, and 25 had mild, moderate, and severe CAA, respectively. Dementia was present in 384 participants (45.3%), of whom 317 had AD. Dementia was more common in those with CAA than without (53.7% vs 40.1%; age-sex-adjusted OR 1.57, 95% CI 1.18-2.10). This association remained significant after separate adjustment for other covariates but lost significance when adjusted for CERAD scores (OR 1.27, 95% CI 0.93-1.71) and Braak stages (OR 0.96, 95% CI 0.69-1.33). Findings from our formal mediation analyses show that ORs (95% CIs) for NIE of CERAD scores and Braak stages were 1.25 (1.13-1.37) and 1.63 (1.38-1.88), respectively, and CERAD scores and Braak stages mediated 53% and 111% of the total association, respectively. DISCUSSION: We observed a significant association between CAA and dementia that disappeared when adjusted for CERAD or Braak stages. Findings from our mediation analyses suggest that the CAA-dementia association may be potentially mediated by AD neuropathologic changes. This hypothesis needs to be tested in future mechanistic studies in AD accounting for unmeasured confounders.
引用
- Sin MK, Cheng Y, Ahmed A, et al. Cerebral Amyloid Angiopathy, Dementia, and Alzheimer Neuropathologic Changes: Findings From the ACT Autopsy Cohort. Neurology. 2024. PMID: 39481068. doi:10.1212/WNL.0000000000210009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。